Insulet Corp. (PODD)
140.60
+1.36
(+0.98%)
USD |
NASDAQ |
Sep 16, 16:00
141.90
+1.30
(+0.92%)
After-Hours: 07:05
Insulet Price : 140.60 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 138.86 | 143.45 | 138.11 | 140.60 | 1.347M |
| Sep 15, 2026 | 137.59 | 140.28 | 136.16 | 139.24 | 1.496M |
| Sep 14, 2026 | 134.23 | 137.98 | 131.61 | 137.80 | 2.344M |
| Sep 11, 2026 | 135.40 | 135.58 | 131.24 | 131.96 | 1.748M |
| Sep 10, 2026 | 136.74 | 138.66 | 134.11 | 134.68 | 1.867M |
| Sep 09, 2026 | 140.26 | 142.69 | 137.25 | 137.92 | 2.059M |
| Sep 08, 2026 | 147.39 | 147.39 | 139.27 | 142.28 | 2.232M |
| Sep 04, 2026 | 149.32 | 150.56 | 145.42 | 147.48 | 1.058M |
| Sep 03, 2026 | 148.14 | 150.99 | 145.16 | 150.58 | 1.158M |
| Sep 02, 2026 | 148.00 | 151.50 | 147.21 | 148.14 | 1.114M |
| Sep 01, 2026 | 149.79 | 151.16 | 146.81 | 148.38 | 1.288M |
| Aug 31, 2026 | 142.93 | 149.68 | 142.00 | 148.66 | 6.635M |
| Aug 28, 2026 | 144.20 | 146.67 | 143.80 | 145.13 | 1.043M |
| Aug 27, 2026 | 142.96 | 144.60 | 140.98 | 143.41 | 1.338M |
| Aug 26, 2026 | 141.27 | 144.64 | 141.23 | 143.38 | 1.424M |
| Aug 25, 2026 | 145.28 | 146.10 | 141.78 | 143.05 | 1.925M |
| Aug 24, 2026 | 151.17 | 151.75 | 145.15 | 145.42 | 1.569M |
| Aug 21, 2026 | 146.87 | 150.20 | 145.04 | 148.16 | 903610.0 |
| Aug 20, 2026 | 151.74 | 152.68 | 146.67 | 146.87 | 1.213M |
| Aug 19, 2026 | 148.00 | 155.17 | 147.96 | 151.51 | 1.311M |
| Aug 18, 2026 | 139.91 | 149.34 | 139.45 | 148.03 | 1.622M |
| Aug 17, 2026 | 141.32 | 142.13 | 138.28 | 139.70 | 1.949M |
| Aug 14, 2026 | 146.98 | 147.17 | 143.02 | 143.34 | 789596.0 |
| Aug 13, 2026 | 145.06 | 146.82 | 143.12 | 146.44 | 1.369M |
| Aug 12, 2026 | 142.00 | 145.59 | 138.70 | 145.06 | 1.571M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| DexCom, Inc. | 87.34 |
| Abbott Laboratories | 102.36 |
| Boston Scientific Corp. | 43.91 |
| PROCEPT BioRobotics Corp. | 19.44 |
| Globus Medical, Inc. | 75.26 |
Price Related Metrics
| PE Ratio | 27.87 |
| PS Ratio | 3.234 |
| PEG Ratio | 0.5209 |
| Price to Book Value | 6.856 |
| Price to Free Cash Flow | 37.17 |
| Earnings Yield | 3.59% |
| Market Cap | 9.751B |
| PEGY Ratio | 0.5209 |
| Operating PE Ratio | 19.16 |
| Normalized PE Ratio | 28.38 |